The conversation around obstructive sleep apnea is changing, and now, so is the way it’s being addressed.
Recent studies have shown that GLP-1 medications, including therapies used for chronic weight management, may help reduce the severity of obstructive sleep apnea in eligible individuals by supporting meaningful weight loss alongside traditional sleep apnea treatment. Resolve’s Sleep & Metabolic Health Program in Ontario with GLP-1/GIP support provides medically supervised assessment and ongoing support through a Nurse Practitioner-led care model to help determine the most appropriate treatment pathway. It is designed to support individuals living with obstructive sleep apnea (OSA) and weight-related health challenges.
By combining obstructive sleep apnea testing, Nurse Practitioner-led assessment, metabolic health support, Registered Dietitian guidance, and access to evidence-based treatment options, the program offers a more connected approach to improving sleep and overall health.
Looking for obstructive sleep apnea treatment in Ontario? Schedule a consultation with Resolve Sleep to learn whether this program may be right for you.
What Is the Connection Between GLP-1 Medications and Obstructive Sleep Apnea?
Obstructive sleep apnea (OSA) and obesity are closely linked. Excess weight can contribute to airway obstruction during sleep, increasing the frequency and severity of apnea events.
Research has shown that meaningful weight loss may significantly improve obstructive sleep apnea symptoms in many individuals. As interest in GLP-1 medications for weight management continues to grow, healthcare providers are increasingly exploring how weight reduction may support better obstructive sleep apnea outcomes when used alongside established therapies such as CPAP or oral appliance therapy.
For this reason, obstructive sleep apnea treatment is increasingly being viewed through a broader metabolic health lens.
Research shows that 60–70% of people with obstructive sleep apnea also live with obesity Clinical studies have also found that losing just 10–15% of body weight can reduce sleep apnea severity by up to 50% (National Library of Medicine).
What Is Resolve Sleep’s GLP-1 Sleep & Metabolic Health Program?
Resolve Sleep’s Sleep & Metabolic Health Program with GLP-1/ GIP support is designed to support individuals living with obstructive sleep apnea who may also benefit from a structured approach to weight and metabolic health management.
It connects patients to structured support across key areas of care, without replacing standard treatments like CPAP when they are needed.
What the program includes:
1. Sleep & Medical Review
- Sleep history review and assessment
- Home sleep apnea testing when indicated
- Objective sleep testing before and after treatment may be used to track progress and symptom improvement
2. Personalized Care Pathways
- Guidance based on sleep test results and health goals
- Options may include CPAP therapy, Oral Appliance Therapy (for snoring and/or obstructive sleep apnea), and lifestyle-focused support
3. Weight & Metabolic Health Support
- Structured programs aimed at supporting sustainable weight management
- Education on how metabolism and sleep interact
4. Ongoing Support & Monitoring
- Continued engagement to help improve adherence to treatment plans
- Adjustments over time to support long-term success
This model aligns with emerging care trends, focusing on progress, sustainability, and whole-body health, not just symptom control.
Who May Qualify for GLP-1 Support for Obstructive Sleep Apnea?
Individuals may be considered for an assessment if they meet specific clinical criteria, including:
- Have a BMI ≥ 30kg/m2 plus moderate to severe OSA
- BMI ≥27 kg/m² plus one or more weight-related health conditions (such as prediabetes or, Dyslipidemia with Fatty Liver or type 2 diabetes)
You may also benefit from the program if you:
- They may have been diagnosed with OSA
- They may struggle with CPAP/OAT therapy
- They have completed a sleep study and still feel exhausted
- They have gained weight and their symptoms have worsened
- They want a medical supervision program— not a generic online prescription
It’s also valuable for those who suspect obstructive sleep apnea but haven’t yet been tested, starting with a home sleep apnea test (HSAT) can provide clarity.
Why This Matters for the Future of Obstructive Sleep Apnea Treatment
The launch of this program reflects a larger industry shift:
- Obstructive sleep apnea is increasingly viewed as a metabolic and systemic condition, not just a breathing issue
- Integrated care models are becoming more accessible
- Patients are seeking simpler, more sustainable ways to manage their health
By bringing these elements together in one program, Resolve Sleep is helping close a critical gap between obstructive sleep apnea and overall health support.
Obstructive Sleep Apnea and Weight Loss Treatment in Ontario
Ontario residents are increasingly seeking integrated healthcare solutions that address both obstructive sleep apnea and the underlying factors that may contribute to it.
Resolve Sleep’s Sleep & Metabolic Health Program helps bridge the gap between:
- Obstructive sleep apnea diagnosis and treatment
- Weight management support
- Metabolic health optimization
- Long-term health improvement
With convenient home sleep testing, Nurse Practitioner-led care, and Registered Dietitian support, Ontario patients can access coordinated metabolic and sleep health services through a single program.
If you live in Ontario and are concerned about obstructive sleep apnea, book a consultation to learn about available testing and treatment options.
Frequently Asked Questions
Research suggests that meaningful weight loss achieved through GLP-1 therapies may help reduce the severity of obstructive sleep apnea in eligible individuals. Whether GLP-1/GIP therapy is appropriate depends on your medical history, symptoms, and clinical eligibility, which can be assessed as part of Resolve Sleep’s medically supervised program.
Resolve Sleep’s Sleep & Metabolic Health Program is a medically supervised program designed for eligible individuals living with obstructive sleep apnea (OSA) and weight-related health challenges. It combines sleep assessment, personalized treatment planning, metabolic health support, and ongoing care from a Nurse Practitioner and Registered Dietitian.
Yes. CPAP remains a standard treatment for obstructive sleep apnea. The program is designed to complement evidence-based obstructive sleep apnea therapies, not replace them.
A Home Sleep Apnea Test (HSAT) can evaluate breathing interruptions during sleep.
Yes. Resolve Sleep’s Sleep & Metabolic Health Program is available for eligible patients in Ontario seeking obstructive sleep apnea testing, treatment, and metabolic health support.
Wegovy® (semaglutide) is approved for chronic weight management in eligible individuals. Research suggests that meaningful weight loss may help reduce the severity of obstructive sleep apnea, particularly in people whose condition is linked to obesity or excess weight.
Obesity is one of the most significant risk factors for obstructive sleep apnea, but it is not the only cause. Factors such as airway anatomy, age, genetics, and certain medical conditions can also contribute to obstructive sleep apnea. However, excess weight can increase pressure on the airway, making breathing interruptions during sleep more likely.
Eligibility is determined through a medical assessment of an individual’s health history, symptoms, weight, and metabolic health.